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Disordered lysosomal/autophagy pathways initiate and drive pancreatitis, but the underlying mechanisms and links to
disease pathology are poorly understood. Here, we show that the mannose-6-phosphate (M6P) pathway of hydrolase delivery
to lysosomes critically regulates pancreatic acinar cell cholesterol metabolism. Ablation of the Gnptab gene encoding a key
enzyme in the M6P pathway disrupted acinar cell cholesterol turnover, causing accumulation of nonesterified cholesterol in
lysosomes/autolysosomes, its depletion in the plasma membrane, and upregulation of cholesterol synthesis and uptake. We
found similar dysregulation of acinar cell cholesterol, and a decrease in GNPTAB levels, in both WT experimental pancreatitis
and human disease. The mechanisms mediating pancreatic cholesterol dyshomeostasis in Gnptab–/– and experimental models
involve a disordered endolysosomal system, resulting in impaired cholesterol transport through lysosomes and blockage
of autophagic flux. By contrast, in Gnptab–/– liver the endolysosomal system and cholesterol homeostasis were largely
unaffected. Gnptab–/– mice developed spontaneous pancreatitis. Normalization of cholesterol metabolism by pharmacologic
means alleviated responses of experimental pancreatitis, particularly trypsinogen activation, the disease hallmark. The
results reveal the essential role of the M6P pathway in maintaining exocrine pancreas homeostasis and function, and
implicate cholesterol disordering in the pathogenesis of pancreatitis.

Introduction

Pancreatitis is a common, potentially fatal disease of the exocrine pancreas. Its pathogenesis remains obscure, and no specific or effective treatment is available (1, 2). Because of the
general lack of access to human tissue, most studies use animal
or ex vivo (cellular) models to investigate pathogenic mechanisms of pancreatitis (3). These models reproduce pathologic
responses of human disease and the spectrum of their severity.
Although defects in other cell types’ function (e.g., ductal; ref.
4) can initiate pancreatitis, damaged acinar cells play a central
role in the disease development (1, 5). The primary function of
these cells is to synthesize, store, and export digestive enzymes,
which relies on coordinated actions of cytoplasmic organelles
to maintain membrane trafficking along secretory and endolysosomal pathways (5).
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Recent studies indicate that lysosomal/autophagy pathways
are impaired in acinar cells in both experimental and human pancreatitis (5–7). Further, genetic alterations specifically targeting
autophagy or lysosomal function can cause spontaneous pancreatitis in mice (8–11). However, the mechanisms whereby impaired
lysosomal/autophagy pathways cause disordering of key acinar
cell organelles, e.g., the ER and mitochondria, and classic pancreatitis responses, such as inappropriate, intra-acinar trypsinogen
activation, are poorly understood (5, 7).
Delivery of newly synthesized hydrolases to lysosomes
involves covalent addition of mannose 6-phosphate (M6P) to
asparagine residues of lysosomal hydrolases in the cis-Golgi
network. The modified hydrolases then bind to one of the two
transmembrane M6P receptors on vesicles that are subsequently directed toward endosomes to deliver their cargo to lysosomes
(12–15). N-acetylglucosamine-1-phosphotransferase is a key
enzyme in the M6P-tag formation; its catalytic α/β subunits are
encoded by the GNPTAB gene (15–17). Ablation of Gnptab in mice
(18, 19) causes pathologic changes in exocrine glands, including
the pancreas, the main manifestation of which is accumulation
of large vacuoles identified by electron microscopy as autolysosomes (19). Accumulation of large vacuoles in acinar cells is
1
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Figure 1. Gnptab ablation perturbs the endolysosomal system in the exocrine pancreas. Characteristics of the endolysosomal system were measured in WT and
Gnptab–/– (KO) pancreatic (A, B, D, and E) tissue, (C) acinar cells, and (F–N) subcellular fractions. (A and D–F) IB analysis of organellar markers/mediators. In this and
other figures, ERK1/2 or GAPDH is the loading control; each lane on tissue IB represents an individual mouse; black line (as in F) indicates lanes are on the same gel
but not contiguous. Ub, ubiquitylated proteins. (B) Immunofluorescence analysis of indicated proteins. In this and other figures, nuclei are stained with DAPI (or
NucRed); DIC denotes differential interference contrast microscopy, displaying zymogen granule area in acinar cells. Scale bars: 10 μm. (C) Acidic organelles stained
using LysoTracker. (D and E) IB showing CatB and CatL pro-form, single-chain (sc), and mature/double-chain (dc) forms. (F–N) Protein levels of indicated markers/
mediators (IB) and cathepsin activities (enzymatic assays) were measured in 3 subcellular pancreas fractions (see Methods): Z, enriched in zymogen granules; L,
enriched in LE/Ly (in WT); and C, cytosol containing. The sum of band intensities for indicated proteins or cathepsin activities in all 3 fractions was taken as 100%.
In F, # indicates that protein load of KO samples was 5 times less than WT. Values are mean ± SEM; each symbol represents an individual mouse (n = 3–6 mice per
condition). *P < 0.05, **P < 0.01, ***P < 0.001 vs. WT tissue (D and E) or corresponding WT fraction (G–N). #P < 0.01 (G and H) or †P < 0.001 (J and K) vs. the other
two fractions. Significance was determined by 2-tailed Student’s t test (D and E) or 1-way ANOVA followed by Tukey’s multiple comparison test (G–N).
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a long-noted response of human and experimental pancreatitis
(20, 21); we have shown that it is mediated by defective autophagy caused by lysosomal dysfunction (6, 22). Both Gnptab –/– pancreas and pancreatitis models display impaired activities and processing of lysosomal hydrolases. These similarities prompted us
to investigate how the blockage of a key endolysosomal pathway
affects the exocrine pancreas.
Here, we show that Gnptab ablation greatly perturbs the
endolysosomal system and autophagy in the exocrine pancreas; in particular, it inhibited endocytic recycling, blocked autophagic flux, and stimulated autophagosome formation. But the
key unexpected finding is that the M6P pathway is critical for
maintaining exocrine pancreas cholesterol homeostasis. Cholesterol levels and its distribution among the plasma membrane
and organelles (endolysosomes, ER, and mitochondria) regulate
their stability and functions (23–26). Disordering of cholesterol
metabolism should be particularly detrimental for acinar cell
homeostasis and functions, as zymogen granule maturation,
secretion, and membrane retrieval and recycling after exocytosis
depend on efficient turnover of membranes’ lipid components.
However, essentially nothing is known about acinar cell cholesterol metabolism in healthy pancreas and its changes in experimental pancreatitis and human disease.
Gnptab ablation caused profound changes in acinar cell cholesterol synthesis, uptake, and subcellular distribution, resulting
in accumulation of nonesterified cholesterol in late endosomes/
lysosomes (LE/Ly) and autophagic vacuoles and its reduction in
the plasma membrane. Gnptab–/– mice spontaneously developed
pancreatitis with all major characteristics of human disease. We
found similar dysregulation of cholesterol metabolism in experimental WT mouse and ex vivo pancreatitis models, while reducing
acinar cell cholesterol overload alleviated disease. Importantly,
we observed manifestations of disordered cholesterol metabolism
in human pancreatitis. The results reveal the essential role of the
M6P pathway in maintaining exocrine pancreas homeostasis and
function, and implicate cholesterol disordering in the pathogenesis of pancreatitis.

Results
Blockage of the M6P pathway disrupts the endolysosomal system,
autophagy, and endocytosis in the exocrine pancreas
Gnptab ablation causes LE/Ly expansion and subcellular redistribution. Gnptab ablation greatly increased pancreatic levels of LE/
Ly markers LAMP1, LAMP2, Rab7, and Rab9 (Figure 1A). Their
immunofluorescence (IF) pattern changed from small puncta in
WT mice to large clumps of various shapes in Gnptab–/– (KO) pancreas (Figure 1B). The expansion and clumping of acidic organelles was also seen with LysoTracker (Figure 1C). In contrast, the
levels of early (Rab5) and recycling (Rab11) endosomal markers
increased only marginally (Figure 1A), and their IF staining (Figure 1B) remained dotted (although the size and cellular distribution of puncta changed somewhat).
Lysosomal hydrolases, such as cathepsins B and L (CatB and
CatL), are synthesized as pro-proteins and undergo proteolytic
processing first in endosomes, generating a partially processed
single-chain (sc) form, and then in lysosomes where at acidic pH

they mature into the fully processed, active double-chain (dc)
form (27). Gnptab deficiency compromised cathepsins’ maturation, as evidenced by increased amounts of the pro-form and 3- to
4-fold increases in sc/dc ratios for both CatB and CatL (Figure 1,
D and E). Reduced sc-to-dc conversion in KO pancreas was also
observed for CatD (19). The inhibition of cathepsin processing/
maturation indicates that the delivery of these proteases to LE/
Ly in pancreas, indeed, depends on the M6P pathway, the involvement of which is organ and cell specific (19, 28).
Of note, the pronounced reduction in the levels of the fully
mature dc form (Figure 1, D and E) did not abrogate CatB and
CatL activities (Figure 1, J and K), indicating that the partially processed sc form possesses considerable catalytic activity.
To further analyze the effect of Gnptab ablation on the endo
lysosomal system, we used (Figure 1, F–N) commonly applied
pancreatic tissue fractionation (6, 29–31) to generate 3 subcellular fractions: Z (1300g pellet), L (12,000g pellet), and C
(12,000g supernatant). In WT pancreas the heavier fraction Z
was enriched in zymogen granule markers (i.e., amylase) and
contained mitochondria (COX IV), whereas the cytosol-containing fraction C was selective for the markers of early endosomes (EE), Rab5 and EEA1 (Figure 1F; see also ref. 6). Fraction
L in WT was enriched in LE/Ly (LAMP2, Rab7, and Rab9) and
exhibited the highest CatB and CatL activities (Figure 1, F–K).
This subcellular distribution is characteristic of healthy cells in
which the level of lysosomal proteolytic activity correlates with
the amount of LE/Ly.
Gnptab ablation altered the subcellular distribution of LE/Ly
and cathepsin activities in the pancreas. LAMP2, Rab7, and Rab9
increased in all 3 fractions, but fraction L exhibited the smallest
increase, resulting in LE/Ly shift away from fraction L to Z and C
(Figure 1, G and H). In contrast, the distribution of EE (Rab5 and
EEA1), zymogen granules (amylase), and mitochondria (COX IV)
did not significantly change (Figure 1, F and I). CatB and CatL
activities increased in fraction C but decreased by half in fractions Z and L, altering cathepsins’ subcellular distribution profile
(Figure 1, J and K). Thus, the substantial LE/Ly expansion in KO
pancreas was not matched/counterbalanced by corresponding
increases in cathepsin activity (as would be expected in cells with
competent LE/Ly), which was evidenced by a greater than 100fold decrease in the ratio of CatB activity to LAMP2 level across
the fractions (Figure 1M).
The data on subcellular redistribution indicate structural
changes in the exocrine pancreas endolysosomal system. Gnptab
ablation caused an imbalance between LE/Ly expansion and their
reduced proteolytic capacity; one underlying mechanism could be
impaired processing/maturation of cathepsins.
Gnptab ablation stimulates autophagosome formation and blocks
autophagic flux
Gnptab ablation greatly increased pancreatic levels of LC3-II (Figure 1F and Figure 2, A–D), a marker of autophagic vacuoles (also
observed in ref. 19). LC3-II levels in KO pancreas increased in all
3 fractions, but more significantly in C, resulting in subcellular
redistribution of LC3-II (Figure 1, F and L). The CatB activity/LC3II ratio markedly decreased (Figure 1N), especially in fractions Z
and L, similar to that for LAMP2 (Figure 1M).
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Figure 2. Gnptab ablation stimulates
autophagosome formation and blocks
autophagic flux in pancreatic acinar
cells. Parameters of autophagy were
measured in WT and Gnptab–/– (KO)
pancreatic (A–C) acinar cells and (D–L)
tissue. (A–C) Acinar cells incubated for
30 minutes with and without bafilomycin A1 (BafA1; 20 nM); LC3-II band
intensity was quantified by densitometry, normalized to ERK in the same
sample, and LC3-II/ERK ratios further
normalized to untreated WT cells
(control). Values are mean ± SEM; each
symbol represents an individual cell
preparation (n = 4–6 per condition).
§
P < 0.05; paired 2-tailed Student’s
t test. (D) IB analysis of autophagic
markers/mediators. Ub, ubiquitylated
proteins. (E–K) Immunofluorescence
colocalization analysis for LC3 and
LAMP1 (E, G, and H), and LC3 and Stx17
(F and I–K) in WT and KO pancreas. In
this and other figures, colocalization
was quantified with Volocity software
using Manders-Costes (percentage
colocalization) and Pearson’s coefficients. Values are mean ± SEM; each
symbol corresponds to 20 to 30 cells
in a different field (n = 6–9 fields from
3 mice per condition). ***P < 0.001 vs.
WT; 2-tailed Student’s t test. (L). EM
showing abnormally large autolysosomes with partially degraded material
in pancreas of KO mice. Scale bars: 10
μm (E and F) and 3 μm (L).

To further assess the effects of Gnptab KO on autophagy, we performed autophagic flux analysis by measuring changes in LC3-II in
acinar cells incubated with and without the lysosomal v-ATPase inhibitor, bafilomycin A1 (BafA1) (Figure 2, A–C). The number of autophagic vacuoles in a cell is a net balance between autophagosome formation and their degradation through autophagic flux. Thus, the increase
in LC3-II observed in KO pancreas (Figure 1F and Figure 2D; see also
Supplemental Figure 6G; supplemental material available online with
this article; https://doi.org/10.1172/JCI146870DS1) could have resulted from both induction of autophagosome formation and the inhibition of flux. BafA1 blocks lysosomal/autophagic degradation but does
not affect autophagosome formation; thus, in the presence of BafA1
any difference in cellular LC3-II levels between 2 conditions (e.g., KO
4

vs. WT) is due solely to changes in autophagosome formation (31, 32).
In the presence of BafA1, LC3-II levels were approximately 11-fold
higher in KO compared with WT (Figure 2, A–C), indicating strong
induction of autophagosome formation in Gnptab–/– acinar cells.
On the other hand, the magnitude of LC3-II increase elicited by BafA1 in a given condition (e.g., WT cells) reflects the efficiency of autophagic degradation in this condition; the greater
the LC3-II increase, the greater was the contribution of autophagic flux abrogated by BafA1 (31, 32). In WT acinar cells, BafA1
increased LC3-II approximately 4-fold (Figure 2C), reflecting
efficient basal autophagic flux, the blockage of which by BafA1
caused accumulation of LC3-positive autophagic vacuoles (31).
Remarkably, in KO cells BafA1 elicited no increase in LC3-II
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Figure 3. Gnptab ablation impairs early-to-late endosome maturation and endocytic recycling. Immunofluorescence analysis of markers of early
(EEA1, TfR, Rab5), recycling (Rab11), and late (LAMP2, Rab7) endosomes in pancreatic (A and C–H) tissue and (B, I, and J) acinar cells (see also
images in the Supplemental Figure 1). In I and J, acinar cells were transduced with both CellLight Rab5-GFP and Rab7-RFP. Quantitative colocalization analysis for indicated proteins was done as detailed in Figure 2. Values are mean ± SEM; each symbol corresponds to 20 to 30 cells in a different field (n = 7–14 fields from 3 to 4 mice or cell preparations per condition). ***P < 0.001 vs. WT; 2-tailed Student’s t test. (K and L) To measure
transferrin (Tf) endocytosis, acinar cells were loaded with Tf-594 at 0°C, transferred to 37°C, incubated for the indicated times, and visualized with
confocal microscopy. Internalized Tf-594 was quantified using Volocity software. Values are mean ± SEM; each symbol corresponds to 10 to 15 cells
in a different field (n = 6–11 fields from 3 WT and 3 KO cell preparations). ***P < 0.001 vs. corresponding WT condition; 1-way ANOVA followed by
Tukey’s multiple comparison test. Scale bars: 10 μm.
J Clin Invest. 2021;131(15):e146870 https://doi.org/10.1172/JCI146870

5

RESEARCH ARTICLE

The Journal of Clinical Investigation  

(Figure 2, A–C), indicating a complete block of autophagic degradation and demonstrating a critical role of the M6P pathway
in maintaining efficient pancreatic autophagy. Together, the
block of autophagic flux and rise in autophagosome formation
increased the basal LC3-II level in Gnptab –/– cells approximately
37-fold compared with WT (Figure 2C).
In accord with these results, we observed marked increases in pancreatic levels of not only LC3-II but also the autophagy
substrate p62/SQSTM1 and ubiquitylated proteins (Figure 2D),
corroborating impaired autophagic degradation (32). Other mediators of autophagosome formation, Beclin1/ATG6, ATG5 (i.e.,
ATG12-ATG5 conjugate), and ATG7, were moderately elevated
(Figure 2D). Gnptab ablation did not block autophagosome fusion
with lysosomes, as evidenced by dramatic increases in LC3-II
colocalization with LAMP1 and acquisition of STX17, a key mediator of this fusion, into LC3-positive puncta in KO acinar cells (Figure 2, E–K). Also, numerous enlarged autolysosomes containing
partially degraded material were seen on electron micrographs of
KO pancreas (Figure 2L and ref. 19).
We found a marked decrease in KO pancreas of EPG5 (Figure
2D), a protein that promotes autolysosomal proteolytic activity
and genetic deletion of which causes formation of nondegradative autolysosomes (33). Together with LC3-II subcellular redistribution and the markedly decreased CatB activity/LC3-II ratio
(Figure 1, L and N), these data support the notion of an imbalance
between increased autophagosome formation and low proteolytic
activity in LC3-positive autophagic vacuoles.
Thus, Gnptab ablation stimulates acinar cell autophagy but
blocks its completion (autophagic flux), resulting in accumulation
of autolysosomes with low degradative capacity.
Gnptab KO impairs EE-to-LE maturation and endocytic recycling. Transport of endocytosed cargos to the lysosome depends
on EE maturation into LE (34, 35), which involves transient formation of hybrid compartments containing markers of both EE (e.g.,
Rab5) and LE (Rab7, LAMP2). In WT pancreas, only approximately 20% of the EE markers EEA1 and transferrin receptor (TfR),
and approximately 4% of the recycling endosomal marker Rab11
colocalized with LAMP2; these values increased up to approximately 70% in KO pancreas (Figure 3, A–H, and Supplemental
Figure 1), indicating impaired EE maturation. IF images (Figure 3, A and B, and Supplemental Figure 1) showed EE markers
trapped within large organelles decorated with ring-like LAMP2,
most clearly seen in KO acinar cell preparations (Figure 3B). Further, Gnptab deficiency increased Rab5/Rab7 colocalization several-fold in acinar cells double-transduced with Rab5a-GFP and
Rab7a-RFP (Figure 3, I and J). Thus, EE maturation is impaired
in the Gnptab –/– pancreas, causing accumulation of hybrid endosomes that bear markers of both EE and LE.
The iron-carrying protein transferrin (Tf) is endocytosed upon
binding its receptor (TfR), releases iron, and is recycled back to the
plasma membrane; this process serves as an archetypical model of
receptor-mediated cargo delivery (35). We measured endocytosis of
fluorescently labeled Tf (Figure 3, K and L), the uptake of which was
initiated by transferring acinar cells from 0°C to 37°C. Immediately
(3 minutes) after initiating endocytosis in WT cells, the labeled Tf
was mostly (~75%) present on the plasma membrane; after 30 minutes, the Tf-TfR complex accumulated in EE, and by 90 minutes it
6

largely returned to the cell surface. By contrast, in Gnptab–/– cells
Tf internalization was already prominent at 3 minutes (suggesting
enhanced Tf endocytosis) but there was no recycling back to the
plasma membrane at 90 minutes (Figure 3, K and L). The results
indicate inhibition of endocytic recycling in KO acinar cells; one
reason for this could be impaired EE-to-LE maturation.
The M6P pathway is critical for maintaining pancreatic cholesterol
homeostasis
Gnptab KO perturbs pancreatic lipids. Numerous lipid-like
inclusions were seen on electron micrographs of KO pancreas, suggesting that the M6P pathway modulates acinar cell lipid metabolism (Supplemental Figure 2A). Whereas WT acinar
cells contained few lipid droplets, blockage of autophagy by
Gnptab ablation or in mice with pancreas-specific knockout of
ATG5 (Atg5Δpan), a key mediator of autophagosome formation,
increased neutral lipids in the pancreas approximately 4-fold
(Supplemental Figure 2, B and C), as measured with the neutral
lipid stain BODIPY 493/503 (36). Similarly, BafA1 treatment
of WT acinar cells increased BODIPY staining approximately
3-fold, and there was no additional effect of BafA1 on the greatly
elevated BODIPY staining in Gnptab –/– cells (Supplemental Figure 2, D and E). (Note that the pattern of BODIPY staining was
different in BafA1-treated WT vs. KO cells.) These results reveal
a key role of autophagy (lipophagy; ref. 37) in maintaining neutral lipid metabolism in the exocrine pancreas.
Accumulation of neutral lipids in KO pancreas was associated with a decrease in perilipins (Supplemental Figure 2, F and G),
proteins essential for the integrity of lipid droplet membranes (38).
We also found increased BODIPY colocalization with both LC3
and LAMP1 (Supplemental Figure 3). Thus, Gnptab ablation caused
accumulation of neutral lipids in LE/Ly and autophagic vacuoles,
while decreasing their cytosolic storage.
Gnptab KO disrupts cholesterol metabolism in the exocrine pancreas. Gnptab ablation increased both the total and nonesterified
(free) cholesterol content in pancreas 3- to 4-fold (Figure 4, A and
B), while it did not significantly elevate triglyceride and free fatty
acid levels (Figure 4, C and D). Corroborating these data, LC-MS/
GC-MS analysis showed several-fold increases in major cholesterol esters in KO pancreas, but not in other classes of lipids tested
(Figure 4E). We further found activation of several mechanisms
that increase free cholesterol: the expression of genes mediating
cholesterol synthesis (Figure 4F), activity of lysosomal acid lipase
(LAL) (Figure 4G), the level of low-density lipoprotein receptor
(LDLR) (Figure 4H), and uptake of exogenous LDL (Figure 4I).
In WT acinar cells (Figure 4, J–L, and Supplemental Figure
4) approximately 40% of filipin, a fluorescent probe for free cholesterol, localized to the plasma membrane (based on its marker
cadherin), and another approximately 40% to zymogen granules
(based on amylase), a distribution pattern similar to that of other
secretory cells (23). Only 5% to 10% of the filipin probe colocalized with markers of LE/Ly (LAMP2, NPC1), EE (EEA1), or autophagic vacuoles (LC3; Figure 4, M–R, and Supplemental Figure 5).
By contrast, in Gnptab –/– acinar cells approximately 84% of filipin
accumulated in organelles wrapped with LAMP2-positive membranes (Figure 4, O and P); a similar colocalization pattern was
seen for filipin and NPC1 on IF images (Supplemental Figure 5A).

J Clin Invest. 2021;131(15):e146870 https://doi.org/10.1172/JCI146870

The Journal of Clinical Investigation  

RESEARCH ARTICLE

Figure 4. Gnptab ablation disrupts cholesterol metabolism in the exocrine pancreas. Parameters of cholesterol metabolism were measured in pancreatic
(A–H) tissue and (I–R) acinar cells. (A–D) Pancreatic contents of total and nonesterified (free) cholesterol, triglycerides, and free fatty acids (FFA); each
symbol represents an individual mouse. (E) Heatmap of lipid species of indicated cholesterol esters (CE), phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS), measured with LC-MS/GC-MS. Each row represents an individual mouse. (F) mRNA expression of proteins
regulating the synthesis of cholesterol and fatty acids was measured by qPCR; each symbol represents an individual mouse. Values were normalized to
the housekeeping gene Rplp0/36B4 and are expressed relative to WT. (G) Lysosomal acid lipase (LAL) activity was measured with a fluorogenic assay. (H)
IB analysis of NPC1, NPC2, and LDLR. (I) LDL uptake was measured with DyLight550-LDL probe; each symbol represents a different cell preparation. (J–R)
Colocalization of the free-cholesterol probe filipin with indicated proteins (see also images in Supplemental Figures 4 and 5) was quantified using confocal
microscopy and the Manders-Costes coefficient. Each symbol corresponds to 10 to 15 cells in a different field (n = 5–11 fields from 3 WT and 3 KO cell preparations). Values are mean ± SEM from 3 to 7 (A and C–G) or 14 to 15 (B) mice of each strain, or from 3 to 4 acinar cell preparations per condition (I and J–R).
**P < 0.01, ***P < 0.001 vs. WT; 2-tailed Student’s t test. Scale bars: 10 μm.
J Clin Invest. 2021;131(15):e146870 https://doi.org/10.1172/JCI146870
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Figure 5. Gnptab–/– mice develop pancreatitis. Parameters of pancreas (A–K) and liver (L and M) damage in KO mice of different age (3 months old [mo] if not
specified). (A and L) Histopathologic changes (H&E staining). (B–F) Pancreatitis responses. In F, macrophage (F4/80), neutrophil (MPO; myeloperoxidase), and
T cell (CD3) infiltration in pancreas was quantified by IHC (see images in Supplemental Figure 8). (G and J) IB analysis of total and phosphorylated (active) NF-κB
(p-p65/RelA) and STAT3 (p-Tyr705-STAT3), and other proteins in pancreas. (H) Proinflammatory cytokines and chemokines were measured (per mg protein) with
Luminex Multiplexing analyzer. (I) The basal/unstimulated amylase secretion was measured as a percentage of its total acinar cell content (see Methods). (K)
Sirius red staining showing pancreatic fibrosis. (M) Serum markers of liver injury. Values are mean ± SEM from 3 to 8 mice of each strain; each symbol represents
an individual mouse or cell preparation. *P < 0.05, **P < 0.01, ***P < 0.001 vs. WT; 2-tailed Student’s t test. Scale bars: 10 μm.
8
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Free cholesterol colocalization with EEA1 and LC3 also increased
several-fold in KO cells, whereas it markedly decreased in both the
plasma membrane and zymogen granules (Figure 4, J–N, Q, and R,
and Supplemental Figures 4 and 5).
NPC1 and NPC2 proteins mediate transport of endocytosed
cholesterol through LE/Ly (39). Similar to other LE/Ly membrane
proteins (LAMP2, Rab7), NPC1 levels greatly increased in KO
pancreas (Figure 4H and Supplemental Figure 6). By contrast, we
observed a marked decrease in NPC2 level in KO pancreas (Figure
4H and Supplemental Figure 6) — in accord with the findings that,
unlike NPC1, NPC2 targeting to LE/Ly is strictly dependent on the
M6P pathway (28, 40).
Thus, blockage of the M6P pathway causes profound disruption of cholesterol homeostasis in the exocrine pancreas. This was
manifested by a marked decrease in plasma membrane cholesterol, critical for maintaining conformation of ion channels and
receptors and cell viability (23–26); reduction of cholesterol in
membranes of zymogen granules (where it is necessary for regulated secretion; ref. 41); and cholesterol accumulation in LE/Ly
and autolysosomes, reducing its availability for the cell’s needs.
Likely as a compensatory response, Gnptab–/– acinar cells upregulated both cholesterol synthesis and uptake. Notably, we did not
observe any significant changes in serum cholesterol levels in
Gnptab–/– mice.
Gnptab KO effects on the endolysosomal system and cholesterol
are organ specific. Gnptab –/– livers exhibited impaired CatB processing (manifested by a decrease in its dc form) and reduced
NPC2 levels (Supplemental Figure 6, A, E, and F), as seen in
KO pancreas. However, there was no upregulation of LAMP2,
Rab7, NPC1, LC3-II, and p62, and no decrease in EPG5 in KO
liver (Supplemental Figure 6, A–D, G, and H). Gnptab deficiency
did not change liver triglycerides, free fatty acids, or total and
free cholesterol (Supplemental Figure 6I). Perilipin 2 (PLIN2)
levels decreased in KO liver, but there was little or no reduction
in PLIN3 and PLIN5 (Supplemental Figure 6, A and J) as seen
in the pancreas (Supplemental Figure 2, F and G). Gnptab ablation did not increase EEA1 colocalization with LAMP2 in the
liver (Supplemental Figure 7A) or BODIPY colocalization with
LAMP2, indicative of neutral lipid accumulation in LE/Ly (Supplemental Figure 7B).
Thus, overall, blockage of the M6P pathway did not significantly perturb the endolysosomal system and neutral lipids in the
liver. In contrast to the pancreas, Gnptab deficiency in the liver did
not cause LE/Ly expansion, accumulation of hybrid endosomes,
or impaired autophagy.
Gnptab–/– mice develop pancreatitis
Acinar cell vacuolization, observed with light microscopy, was
evident in 1.5-month-old KO mice, and vacuole size and pancreas
disorganization increased with age (Figure 5A). In addition to histopathologic changes, by 3 months Gnptab –/– mice developed signature responses of pancreatitis (1, 3): increased levels of serum
amylase and lipase, inflammation, parenchymal necrosis, and
increased caspase-3–like activity indicative of apoptosis (Figure 5,
B–F); as well as an upsurge in intrapancreatic trypsin activity (see
below). Inflammatory infiltration in the pancreas was driven by
macrophages and T cells, and not neutrophils (Figure 5F and Sup-

plemental Figure 8), which is a pattern characteristic of a chronic
inflammatory response. We observed activation (i.e., phosphorylation) of the proinflammatory transcription factors NF-κB and
STAT3 in KO pancreas (Figure 5G) and increased levels of cytokines and chemokines, such as LIF, IL-3, IL-4, and CCL11/eotaxin-1 (Figure 5H). Pancreatic levels of CHOP, an ER stress marker
and cell death mediator, markedly increased (Figure 5G); those of
amylase and trypsinogen decreased (Figure 5J), indicating exocrine pancreas atrophy. Basal (unstimulated) amylase secretion
was inhibited in KO acinar cells (Figure 5I). Pancreatic fibrosis
was evidenced by upregulation of α-SMA, a marker of activated
stellate cells (Figure 5G), and by Sirius red staining (Figure 5K).
In contrast, Gnptab–/– liver displayed no vacuolization or other
histopathologic changes, and the serum markers of liver damage,
alanine (ALT) and aspartate (AST) aminotransferases, were only
mildly elevated (Figure 5, L and M).
The results show that blockage of the M6P pathway causes
spontaneous pancreatitis in mice.
Trypsin activity cholesterol-dependently increases in Gnptab–/– pancreas
Gnptab deficiency greatly increased intrapancreatic trypsin activity (Figure 6A), also evidenced by increased levels of trypsinogen activation peptide (TAP) (Figure 6, E and F), an oligopeptide
cleaved off trypsinogen during its conversion to active trypsin (6,
42). The inappropriate, intra-acinar trypsinogen activation is a
hallmark of pancreatitis but its mechanism, and the site(s) where
it occurs, remain obscure (5, 43). In experimental pancreatitis it
is mediated by CatB (6, 43, 44), and, indeed, the CatB inhibitor
CA-074Me reduced trypsin activity in Gnptab–/– acinar cells by
half (Figure 6B). In normal secretory cells, the nascent immature
secretory granules, due to imperfect sorting, have an admixture of
lysosomal enzyme precursors, although the majority of their content are secretory proteins. During granule maturation, hydrolases
are removed through an M6P receptor–mediated mechanism (discussed in ref. 5). Because in KO pancreas cathepsins lack the M6P
tag, this mechanism is compromised and one might presume that
CatB is retained (i.e., mis-sorted) in mature zymogen granules
(19) and activates trypsinogen there. However, CatB colocalization with trypsinogen did not increase in KO pancreas (Figure 6,
C and D), arguing against the predominance of this mechanism.
(Note that CatB colocalization with trypsinogen is fairly robust in
WT acinar cells, Pearson’s coefficient; Figure 6D).
Instead, Gnptab ablation greatly increased TAP colocalization
with LAMP2 and LC3 (Figure 6, E–H). Further, BafA1 reduced
trypsin activity in KO acinar cells by half (Figure 6B). These results
indicate trypsin localization in acidic CatB-containing organelles,
as also supported by the subcellular fractionation data. In WT
pancreas, trypsinogen mostly localized to fraction Z (enriched in
zymogen granules) and the bulk of trypsin activity was in the Z and
L fractions (Figure 6, I–K). Gnptab deficiency did not change the
subcellular distribution of trypsinogen (Figure 6, I and J; as also
seen for amylase, another zymogen granule protein, Figure 1F).
However, the percentage of trypsin activity in fraction Z decreased
in KO pancreas, while its largest (~4.7-fold) increase was in fraction C (Figure 6, K and L), which contained EEA1 and Rab5 and
harbored large increases in LC3-II and LAMP2 levels and CatB
activity (Figure 1, F, G, I, J, and L).
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Figure 6. Mechanisms mediating increased trypsin activity in Gnptab–/–
pancreas. Trypsin activity and its regulation were analyzed in pancreatic
(A, C, and D) tissue, (B and P–R) acinar cells, (E–H and O) lobules, and (I–N)
subcellular fractions. In B, acinar cells were incubated for 3 hours without
and with 20 nM BafA1 or 50 μM CatB inhibitor CA-074Me; in P–R, with the
cholesterol chelator methyl-β-cyclodextrin (MCD) at the indicated concentrations. In E–H, pancreatic lobules were double stained for TAP and LC3 or
LAMP2; in O, for TAP and filipin. Quantitative colocalization analysis was
done as detailed in Figure 2. Each symbol in A, B, J–N, Q, and R represents
an individual mouse or cell preparation (n = 3–8 per condition). Each symbol in D, G, and H corresponds to 20 to 30 cells in a different field (n = 9–20
fields from 3 WT and 3 KO mice or lobule preparations). Values are mean ±
SEM. **P < 0.01, ***P < 0.001 vs. WT tissue/lobules (A, G, and H) or corresponding WT subcellular fraction (K and M). ##P < 0.01 vs. no inhibitors (B)
or MCD (Q and R). ††P < 0.01, †††P < 0.001 vs. the other two fractions (L and
N). Significance was determined by 2-tailed Student’s t test (A, G, and H)
or 1-way ANOVA followed by Tukey’s multiple comparison test (B, K–N, Q,
and R). Scale bars: 10 μm.

The subcellular distribution of trypsin activity in KO pancreas
was similar to that of cholesterol, in that the greatest increase in
both was in fraction C (Figure 6, K–N). TAP colocalized with filipin-positive structures (Figure 6O); furthermore, reducing cholesterol content with its chelator, methyl-β-cyclodextrin (MCD),
greatly decreased trypsin activity in KO cells (Figure 6, P–R). Of
note, Gnptab–/– acinar cells were highly resistant to MCD, with the
cholesterol-reducing effect evident only at 50 mM MCD (Figure 6,
Q and R) instead of the usual 1 to 5 mM (45).
The results show that the M6P pathway regulates intrapancreatic trypsin activity in a cholesterol-dependent manner, and
implicate endosomal and autophagic compartments — but not
zymogen granules — as the sites of trypsinogen activation in Gnptab –/– acinar cells. Our data are consistent with the notion that the
colocalization organelles may originate from fusion of trypsinogen-containing autophagosomes with endosomes (such as the
hybrid EE/LE) in which the partially processed (sc form) CatB is
active; these amphisomes may subsequently fuse with lysosomes.
The observed increases in both trypsin activity and cholesterol
in fraction C could be explained by accumulation of low-density,
cholesterol-rich autophagic vacuoles in this fraction. The mechanisms through which cholesterol regulates trypsinogen activation
in pancreatitis remain to be determined.
Gnptab ablation causes mitochondrial dysfunction in the pancreas
Mitochondrial dysfunction drives pancreatitis in experimental
mouse and cellular models and is associated with human disease
(5, 46–48). However, the role of the endolysosomal system, in particular the M6P pathway, in pancreatic mitochondrial homeostasis
has not been explored. We found pronounced mitochondrial dysfunction in Gnptab –/– pancreas, manifested by reduced enzymatic
activities of electron transport chain (ETC) complexes II and IV
(Figure 7A); decreased rates of basal, ATP-linked, and maximal
oxygen respiration (oxygen consumption rate, OCR) (Figure 7, B
and C); and a marked decrease in pancreatic ATP level (Figure 7E).
In WT pancreatic mitochondria, ADP-stimulated ATP synthesis
caused a decrease in mitochondrial membrane potential (ΔΨm),
which returned to basal levels after ADP was converted to ATP
(Figure 7D). In contrast, the ΔΨm recovery following ADP addition was greatly inhibited in Gnptab –/– mitochondria (Figure 7D),

indicating impaired ATP synthase function (46). Levels of Fis1, a
protein involved in mitochondrial fragmentation, and Parkin, a
mitophagy mediator (49), increased in KO pancreas (Figure 7F).
The increase in mitochondrial fragmentation was evidenced by IF
of the mitochondria-resident proteins Tom20 and VDAC, which
showed a disjoined and mostly circular pattern in KO pancreas, in
contrast with the interconnected tubular mitochondrial network in
WT (Figure 7G). Of note, Gnptab ablation did not decrease immunoblot (IB) levels of mitochondrial markers, i.e., the outer mitochondrial membrane protein Tom70 and the inner mitochondrial
membrane protein COX IV (Figure 7H), indicating no decrease in
the amount of mitochondria in KO pancreas.
Collectively, the results show a major role of the M6P pathway
in maintaining acinar cell mitochondrial functions.
Some of the mitochondrial defects in Gnptab–/– pancreas could
be the result of perturbed lipid metabolism. Specifically, ATP production in WT acinar cells is mediated by free fatty acid oxidation,
as evidenced by inhibition of both basal and ATP-linked OCR with
etomoxir (Figure 7I), a β-oxidation inhibitor (50). In KO acinar cells,
the respiration rates were much lower and not significantly reduced
by etomoxir (Figure 7I). One reason for this could be the approximately 2-fold decrease in free fatty acid content in KO pancreatic
mitochondria (Figure 7J), likely a consequence of reduced availability of lipid droplets (Supplemental Figures 2 and 3) that deliver
free fatty acids to mitochondria (51). With LC-MS/GC-MS, we also
showed increased levels of long-chain acylcarnitines in KO pancreas (Figure 7K), an indication of impaired β-oxidation (52, 53).
We further found that the cholesterol content of Gnptab–/– pancreatic mitochondria increased approximately 2.5-fold (Figure
7M), which is damaging for mitochondrial functions (24, 54). Elevated cholesterol interferes with assembly of ETC complexes and
thus could be responsible for their reduced activity and dysregulation of mitochondrial ATP synthesis (Figure 7, A–E). One likely
mechanism mediating mitochondrial cholesterol overload in KO
pancreas is the increase in MLN64/STARD3 protein (Figure 7L),
which belongs to the STARD family of lipid transfer proteins that
transport cholesterol directly from LE/Ly to mitochondria. This
pathway is activated in conditions of inhibited cholesterol egress
from lysosomes, and STARD protein levels increase in response
to a defective supply of cholesterol to mitochondria via normal
routes (24, 55, 56). A similar paradoxical effect of mitochondrial
cholesterol overload despite disrupted cholesterol turnover, as
well as increased levels of STARD protein, was observed in Niemann-Pick type C (NPC) disease models (55).
Notably, in contrast to pancreas, Gnptab deficiency in liver mitochondria did not alter ETC complex activities, the ADP-mediated
ΔΨm response, cholesterol content, or MLN64 levels (Figure 7, N–Q).
Cholesterol metabolism is disrupted in experimental pancreatitis
Lipidomic and enzymatic analyses showed increases in pancreatic total cholesterol in 3 dissimilar acute pancreatitis (AP) models
induced in WT mice using L-arginine (Arg-AP), the CCK-8 ortholog cerulein (CER-AP), or choline deficient, ethionine-supplemented diet (CDE-AP) (Figure 8, A and B). Similarly, cholesterol
content increased in mouse (Figure 8C) and, notably, human (Figure 8D) acinar cells stimulated with supramaximal (100 nM) CCK8 (CCK-AP) or carbachol (ex vivo AP models). Physiologic doses
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Figure 7. Gnptab ablation causes mitochondrial dysfunction in the pancreas. Mitochondrial functional parameters were measured in mitochondria isolated from pancreas (A, D, J, and M) or liver (N–P), in acinar cells (B, C, and I), and pancreatic (E–H, K, and L) and liver (Q) tissues of WT and KO mice. (A and N)
Activities of mitochondrial ETC complexes I, II, IV, and V. (B, C, and I) Acinar cell oxygen consumption rates (OCR), reflecting mitochondrial OXPHOS, were
measured in basal conditions and after treatment with the β-oxidation inhibitor etomoxir (40 μM), and normalized to total protein in the sample. (B) Representative OCR tracings in acinar cell suspension subjected to consecutive injections of the ATP synthase inhibitor oligomycin (Oligo; 3 μM), protonophore
FCCP (2.7 μM), and mitochondrial uncouplers rotenone plus antimycin A (R+A, 5 μM each; to correct for nonmitochondrial respiration). (C and I) ATP-linked
respiration was calculated as the difference between basal OCR and that in Oligo-treated cells; the maximal OCR was obtained in FCCP-treated cells. (D
and O) Mitochondrial membrane potential (ΔΨm) was measured with a tetraphenyl phosphonium ion (TPP+) electrode. FCCP (5 μM) was added to completely dissipate ΔΨm. (E) ATP was measured in pancreatic tissue homogenate with luciferin-luciferase assay. (F, H, L, and Q) IB analysis of the mitochondrial fission factor Fis1 and mitophagy mediator Parkin (F), mitochondrial markers (H), and MLN64/STARD3 protein (L and Q) that mediates cholesterol
transfer from LE/Ly directly to mitochondria. (G) Mitochondrial fragmentation was assessed by changes in Tom20 or VDAC immunostaining pattern, from
an interconnected tubular mitochondrial network in WT to a predominantly disjoined/circular one in KO pancreas. Scale bars: 10 μm. (J, M, and P) Free fatty acid (FFA) and cholesterol contents of isolated pancreatic or liver mitochondria. (K) Long-chain acylcarnitines were measured with LC-MS/GC-MS. Values are mean ± SEM; each symbol represents an individual mouse, or cell or mitochondria preparation (n = 3–8 per condition). *P < 0.05, **P < 0.01, ***P <
0.001 vs. the same parameter in WT. #P < 0.05 vs. the same condition without etomoxir (I). Significance was determined by 2-tailed Student’s t test.
12
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Figure 8. Derangement of cholesterol metabolism in experimental pancreatitis. Characteristics of cholesterol metabolism were measured, as detailed in
Figure 4, in pancreas of WT mice subjected to pancreatitis induced with cerulein (CER-AP), L-arginine (Arg-AP), or CDE diet (CDE-AP) (A, B, and E–G); ex vivo
pancreatitis induced in WT mouse (C and I–M) or human acinar cells (D) with 100 nM CCK (CCK-AP) or 1 mM carbachol; and isolated pancreatic mitochondria
(H). (B) Cholesterol ester (CE) heatmap; each column represents an individual mouse. (F) IB analysis of the indicated proteins. (G) LAL activity was measured
by a fluorogenic assay (n = 6 mice per condition). (H) Cholesterol content was measured by enzymatic assay. (I–M) Filipin colocalization with indicated proteins
was quantified as detailed in Figure 2. Each symbol in A, C–E, and H represents an individual mouse, or cell or mitochondria preparation (n = 3–15 per condition). Each symbol in J, K, and M corresponds to 20–30 cells in a different field (n = 10–20 fields from 3 cell preparations per condition). Values are mean ± SEM.
*P < 0.05, **P < 0.01, ***P < 0.001 vs. the same parameter in control/untreated pancreas, acinar cells or isolated mitochondria. Significance was determined
by 2-tailed Student’s t test (B, E, H, J, K, and M) or 1-way ANOVA followed by Tukey’s multiple comparison test (A, C, and D). Scale bars: 10 μm.

of CCK (10 pM) or carbachol did not alter total cholesterol in acinar cells, and pancreatic triglycerides were unchanged in CER-AP
(Figure 8C, and data not shown).
We examined in more detail the changes in acinar cell cholesterol metabolism in CER/CCK-AP, the most widely used animal
and ex vivo pancreatitis model (3). Similar to Gnptab –/– (Figure 4),
in WT mice with CER-AP we found upregulation of pancreatic
mRNA expression for enzymes mediating cholesterol synthesis

(Figure 8E), increased protein levels of LDLR and SREBP2 (Figure
8F) and LAL activity (Figure 8G), and elevated mitochondrial cholesterol (Figure 8H). Further, the plasma membrane free cholesterol (i.e., filipin colocalization with cadherin) markedly decreased
in the ex vivo CCK-AP model, concomitant with its accumulation
in Rab7-positive LE/Ly (Figure 8, I–M). These changes are similar
to those seen in KO pancreas. As in Gnptab–/– mice, serum cholesterol levels did not change in CER-AP.
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Figure 9. Cerulein pancreatitis decreases pancreatic levels
of GNPTAB and mediators of cholesterol trafficking
through LE/Ly. (A, D, and E) IB analysis of the indicated
proteins in pancreas of WT mice subjected to CER-AP and in
Gnptab–/– mice. NS, nonspecific band. (B and C) Cholesterol
content was measured in pancreas of (B) WT mice that
received daily i.p. injections of the NPC1 inhibitor U18666A
(10 mg/kg) or vehicle for 15 days and (C) Lamp2–/– mice.
Each symbol in B, C, and E represents an individual mouse.
Values are mean ± SEM from 3 to 5 mice per condition.
***P < 0.001 vs. the same parameter in WT control/untreated or saline-treated mice. Significance was determined by
2-tailed Student’s t test (B and C) or 1-way ANOVA followed
by Tukey’s multiple comparison test (E).

We tested whether experimental pancreatitis altered the
NPC2/NPC1 pathway that mediates cholesterol transport
through LE/Ly (39). Unlike Gnptab –/– pancreas, there was no
change in NPC2 levels, but pancreatic NPC1 greatly decreased
in CER-AP (Figure 9A). Administration of U18666A, a selective
NPC1 inhibitor (57), elevated cholesterol content in WT mouse
pancreas (Figure 9B). We found a similar increase in pancreatic
cholesterol in mice deficient in LAMP2 (Figure 9C), another LE/
Ly protein mediating cholesterol trafficking (58). Of note, pancreatic LAMP2 levels greatly decrease in various pancreatitis models, including CER-AP (Figure 9A), as well as in human disease
(8). The results in U18666A-treated WT mice and in Lamp2–/–
mice (Figure 9, B and C) confirm the role of NPC1 and LAMP2 in
regulating pancreatic cholesterol.
We found that CER-AP elicited an approximately 5-fold
decrease in pancreatic GNPTAB α-subunit protein level (Figure
9, D and E). This effect could mediate alterations in cholesterol
metabolism that we observed in experimental pancreatitis. The
fact that the NPC2 level was not reduced in CER-AP (Figure 9A),
despite a marked decrease in GNPTAB α-subunit, may indicate
increased NPC2 synthesis, blocked excretion, or a threshold pattern of its regulation by the M6P pathway in the pancreas.
Cholesterol normalization ameliorates experimental pancreatitis
We found (Figure 10, A–F) that, as in Gnptab–/– mice, cholesterol
regulates trypsinogen activation in WT experimental pancreatitis.
Cholesterol overload (using cholesterol-loaded MCD) increased
basal trypsin activity in WT acinar cells (Figure 10, A and B), whereas depleting cholesterol with MCD reduced CCK-induced trypsinogen activation in ex vivo pancreatitis (Figure 10, C and D). In accord
with these data, T0901317, which promotes cholesterol efflux by
activating the LXR receptor (59, 60), and simvastatin, an inhibitor
of cholesterol synthesis, ameliorated experimental pancreatitis in
WT mouse and ex vivo models. Both compounds eliminated pancreatitis-induced increases in total cholesterol and trypsin activity
(Figure 10, E and F). Of note, the same T0901317 or simvastatin
14

treatments of Gnptab–/– mice, even for 3 weeks, failed to decrease
pancreatic total cholesterol levels, confirming the resistance of KO
acinar cells to reducing cholesterol overload (see Figure 6, Q and
R). T0901317 and simvastatin improved pancreas histopathology in CER-AP (Figure 10G and Supplemental Figure 9A); reduced
accumulation of LC3-II, p62, and ubiquitylated proteins, indicating
more efficient autophagy; and decreased CHOP levels, indicating
lower ER stress (Figure 10, H and I, and Supplemental Figure 9B).
T0901317 and simvastatin also normalized mitochondrial fragmentation, as assessed by Tom20 IF (Figure 10J), and abrogated
the CER-induced increase in MLN64 (Supplemental Figure 9B). In
addition to improved histopathology, simvastatin also ameliorated
other pancreatitis responses (Supplemental Figure 9C).
To examine the effect of disrupted cholesterol turnover, we
incubated WT acinar cells with LDL-cholesterol in the presence and
absence of the NPC1 inhibitor U18666A. U18666A caused cholesterol accumulation in LE/Ly (filipin staining; Figure 10K), resulting
in impaired autophagy (manifested by concomitant accumulation
of LC3-II and ubiquitylated proteins) and increases in CHOP and
Parkin (Figure 10L). Similarly, mice that received U18666A and
thus had elevated total cholesterol (Figure 9B) exhibited pancreas
damage manifested by increased acinar cell vacuolization, necrosis
(up to ~20%), and inflammation (Figure 10M), and accumulation of
LC3-II, p62, and ubiquitylated proteins (Figure 10N).
Taken together, amelioration of experimental pancreatitis
with T0901317 and simvastatin, and the detrimental effects of
U18666A suggest that disordered acinar cell cholesterol metabolism mediates impaired autophagy, ER stress, and other pathologies of pancreatitis.
Human pancreatitis displays signs of disordered acinar cell cholesterol
homeostasis
Using IF analysis of deidentified tissue sections from patients
with and without pancreatitis, we found an approximately 3-fold
increase in pancreatic HMG-CoA reductase, and dramatic
decreases in NPC1 and GNPTAB levels in pancreatitis tissues (Fig-
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ure 11). The specificity of the anti–GNPTAB α-subunit antibody
was confirmed by IB analysis (Figure 9D). None of the patients,
except one, had pancreatic adenocarcinoma (Supplemental Table
1). Remarkably, both the direction and magnitude of the changes we observed in human disease are similar to those presented
above in experimental models of pancreatitis.

Discussion

Our study in Gnptab–/– mice reveals that an efficient endolysosomal
system and autophagy, and in particular the M6P pathway, are critical for maintaining cholesterol metabolism in the exocrine pancreas. We find that cholesterol derangement mediates experimental
pancreatitis pathologies, and that the human disease displays signs
of impaired acinar cell cholesterol homeostasis. Our results show a
central role of the M6P pathway in key exocrine pancreas cellular
processes: autophagy, endocytosis, and mitochondrial functions;
and establish Gnptab–/– mice as a genetic model of pancreatitis.
Gnptab ablation perturbed the acinar cell endolysosomal system, manifested by underprocessing of cathepsins and the expansion of LE/Ly that was not matched by an increase in cathepsins’
activities, resulting in diminished lysosomal proteolytic capacity.
We found impaired EE-to-LE maturation causing accumulation of
hybrid endosomes. In turn, the major functions of the endolysosomal system, autophagy and endocytic recycling, were severely
compromised. Gnptab deficiency both stimulated autophagosome
formation in acinar cells and blocked autophagic flux, causing
accumulation of large nondegradative autolysosomes. Deranged
endocytosis was manifested by increased Tf internalization and
inhibition of its recycling.
We find that Gnptab deficiency greatly perturbed many aspects
of cholesterol metabolism, as reflected by several-fold increases
in total and free cholesterol, upregulated expression of proteins
mediating cholesterol synthesis, and increased LDL uptake. In
contrast to WT, free cholesterol in KO acinar cells accumulated in
large LAMP2-positive structures occupying the bulk of the cytoplasm. This was associated with a deleterious cholesterol reduction in the plasma membrane and zymogen granules. Of note, the
distribution of cholesterol among subcellular membranes is highly
uneven. In healthy cells, most of cellular cholesterol is localized
to the plasma membrane to maintain its proper fluidity and rigidity, as well as to secretory granules; by contrast, mitochondria and
lysosomes contain minor amounts of cholesterol (23–26).
The results indicate that two major mechanisms mediating
these effects are defective cholesterol trafficking through LE/Ly
and blockage of autophagic flux. We find that autophagy/lipophagy plays a key role in lipid droplet degradation in normal pancreas, and its impairment results in accumulation of neutral lipids in
nondegradative autolysosomes, making free cholesterol unavailable for the cell’s needs. In response, Gnptab –/– acinar cells upregulate both cholesterol synthesis and uptake, which exacerbates
cholesterol derangement by further increasing its content.
This paradoxical response, and other alterations in cholesterol metabolism in Gnptab–/– pancreas, resemble those observed
in the lysosomal storage disease NPC. The disease is caused by
mutations in NPC2 or NPC1, proteins that mediate cholesterol
transport through LE/Ly (39, 58). NPC2 lacking the M6P recognition marker fails to reach lysosomes and is secreted (28, 40).

Congruently, NPC2 levels greatly decreased in Gnptab –/– pancreas,
likely mediating cholesterol accumulation in LE/Ly. Mouse NPC
models showed structural alterations in pancreatic acinar cells,
e.g., lipid accumulation in lysosomes and a reduction in secretory
granules (61, 62); pancreas damage in NPC patients has not been
examined. However, there have been no reports of pancreatitis in
NPC patients (or mouse models), suggesting that NPC2 deficiency by itself is insufficient to cause disease.
Gnptab ablation caused pancreatic mitochondrial failure evidenced by decreased ETC complex activities and oxidative phosphorylation (OXPHOS), impaired ATP synthesis, and increased
mitochondrial fragmentation. The results reveal a critical role
for the M6P pathway in maintaining mitochondrial functions in
the pancreas. Our data implicate several mechanisms mediating
mitochondrial failure in Gnptab–/– pancreas. One is the blockage
of autophagy/mitophagy, causing accumulation of dysfunctional mitochondria. Another is perturbed neutral lipid metabolism,
resulting in impaired β-oxidation and increased mitochondrial
cholesterol. The latter can impede ETC complex formation and
ATP synthesis (24, 54).
In contrast to the pancreas, Gnptab–/– livers did not exhibit pathologic changes in the endolysosomal system, autophagy,
mitochondrial functions, or cholesterol content. This is consistent
with a previous study showing organ-specific effects of Gnptab
ablation (19), likely due to varying contributions of compensatory,
M6P-independent mechanisms of acid hydrolases’ targeting to
endolysosomes (28). However, some effects were shared by KO
pancreas and liver, such as the markedly decreased levels of perilipin 2, a critical lipid droplet protein (38), revealing a role for the
M6P pathway in lipid droplet homeostasis.
In humans, mutations in the GNPTAB gene cause mucolipidosis type II (MLII), a fatal disease characterized by damage to
mesenchymal cells (i.e., skin fibroblasts) and skeletal and other abnormalities (15, 16, 61). Some, but not all, of these defects
are observed in mice with an MLII patient’s GNPTAB mutation
knocked in (15). Gnptab –/– mice, in which the gene is completely
ablated by retroviral gene trapping, do not replicate MLII pathology (18, 19, 28); in particular, there is not much damage to fibroblasts. However, these mice provide a valuable tool to study the
roles and mechanisms of endolysosomal and autophagy pathways in secretory cells (this study and ref. 19). Pancreatitis has not
been reported in MLII patients, but an autopsy study of juvenile
MLII patient (63) found extensive damage (i.e., massive vacuolization) in several secretory glands including exocrine pancreas. The remarkably variable sensitivity of different organs and
cell types to defects in GNPTAB, observed in both MLII patients
and mouse models (15, 16, 19, 28), reflects the contribution of
alternative and compensatory, M6P-independent mechanisms
(as well as interspecies differences). The difference between the
effects of a mutated (15) versus fully ablated Gnptab gene (this
study and refs. 18, 19) may also indicate a role for protein-protein interactions involving GNPTAB, in addition to its enzymatic
function. Of note, the ablation of the cation-independent M6P
receptor in mice (64) caused much less pancreas damage than in
Gnptab –/– (though it worsened experimental pancreatitis), possibly indicating a compensatory contribution of the second, cation-
dependent, M6P receptor.
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Figure 10. Deranged cholesterol metabolism causes acinar cell damage,
while its normalization ameliorates experimental pancreatitis. (A–D)
Cholesterol content and trypsin activity were measured (per mg protein) in
WT mouse acinar cells incubated for 1 hour without and with methyl-β-cyclodextrin (MCD; 10 mM) or cholesterol-loaded MCD (MCD-Chol; 200 μg/
mL), in the presence or absence of 100 nM CCK. Values are expressed relative to those in cells without MCD/MCD-Chol. (E–J) WT mice received daily
i.p. injections of the LXR agonist T0901317 (T09), simvastatin (Sim; 20
mg/kg each), or vehicle. On day 4, mice were subjected to CER-AP and pancreata collected for analyses (see also Supplemental Figure 9). Cholesterol
content (E), trypsin activity (F), and pancreas histopathology (H&E staining; G) were measured. (H, I, L, and N) IB analysis of markers/mediators of
autophagy (LC3, p62), ER stress (CHOP, GRP-78), and mitophagy (Parkin).
Ub, ubiquitylated proteins. (J) Mitochondrial fragmentation was assessed
by immunostaining for Tom20, as detailed in Figure 7G. (K and L) Mouse
acinar cells were treated for 16 hours with LDL (30 μg/mL) or the combination of LDL and 10 μM U18666A. (M and N) Mice received injections of
U18666A as detailed in Figure 9B. Pancreas histopathology (H&E staining;
M) and levels of autophagy markers/mediators (N) were measured. Each
symbol in A–F and I represents an individual mouse or cell preparation.
Values are mean ± SEM from 3 to 7 mice or cell preparations per condition.
§
P < 0.05, §§P < 0.01 vs. control cells (without MCD/MCD-Chol). ***P <
0.001 vs. saline-treated mice. #P < 0.05, ##P < 0.01, ###P < 0.001 vs. CERAP alone (no inhibitors). Significance was determined by 2-tailed Student’s
t test (A–D) or 1-way ANOVA followed by Tukey’s multiple comparison test
(E, F, and I). Scale bars: 10 μm.

We show that Gnptab–/– mice spontaneously develop pancreatitis with all key manifestations of human disease. Together with
recent studies (8–11, 65), the results support our conjecture (5) that
secretory cells, such as pancreatic acinar cells, rely heavily on efficient endolysosomal functions and autophagy and are particularly sensitive to their impairment. In particular, the basal secretion
was significantly decreased in Gnptab–/– acinar cells. In addition, a
recent study (66) showed that efficient lysosomal proteolytic degradation is required for cellular reprogramming into a regenerative phenotype and that Gnptab deficiency profoundly impairs the
pancreas’s ability to regenerate after CER-induced injury.
Prompted by the results in Gnptab–/–, we found that experimental
pancreatitis in WT mouse and ex vivo models greatly perturbed acinar cell cholesterol metabolism. Similar to Gnptab–/– pancreas, total
cholesterol content was elevated in several unrelated acute pancreatitis models. Experimental pancreatitis caused cholesterol accumulation in LE/Ly and autolysosomes, reduced free cholesterol in the
plasma membrane, and increased the expression of proteins mediating cholesterol synthesis, LDLR levels, and mitochondrial cholesterol. Both Gnptab ablation and experimental pancreatitis disrupted
cholesterol transport through LE/Ly but by different mechanisms;
the former reduced the NPC2 level, while the latter decreased NPC1
(as well as LAMP2 [ref. 8], another LE/Ly cholesterol transporter).
We showed that cholesterol is involved in the regulation
of intra-acinar trypsinogen activation, a signature pancreatitis
response, the mechanism of which remains obscure (6, 43, 67,
68). Trypsin activity increased with cholesterol overload, while
in both Gnptab –/– acinar cells and WT experimental pancreatitis
it was reduced by decreasing cholesterol content with different
approaches. Inhibiting cholesterol turnover with U18666A caused
impaired autophagy and ER stress in acinar cells, whereas alleviating cholesterol overload with T090137 or simvastatin reduced
these and other pathologic responses of experimental pancreati-

tis. Simvastatin also abrogated the increase in pancreatic MLN64
caused by CER-AP. Collectively, the results reveal the critical role
of cholesterol in maintaining acinar cell homeostasis and implicate its derangement in pancreatitis development.
The finding of manifestations of disordered acinar cell cholesterol homeostasis in human pancreatitis supports our conclusions
from mouse and cellular models. In particular, the reduction in
NPC1, together with our previous finding of a dramatic LAMP2
decrease in human pancreatitis (8), strongly indicate deranged
cholesterol trafficking through LE/Ly in human disease. The
decrease in pancreatic GNPTAB levels, observed in both human
disease and an experimental model, further justifies Gnptab –/–
mice as a genetic pancreatitis model.
Dysregulation of acinar cell cholesterol is a previously unrecognized pathology of pancreatitis. In fact, very little is known
about basal cholesterol metabolism in the exocrine pancreas,
the maintenance of which should be critical for acinar cells, as
zymogen granule formation, secretion, and membrane recycling/
retrieval all require precise and adequate lipid supply. One likely
reason for this lack of knowledge is that human pancreatitis has
not been associated with changes in blood cholesterol. This disconnect is reminiscent of NPC patients who have normal serum
cholesterol levels despite fatal defects in cholesterol metabolism
in many organs (69, 70). Likewise, we did not observe changes in
serum cholesterol in either Gnptab–/– or experimental pancreatitis.
However, there have been epidemiologic studies on the
effects of statins on pancreatitis severity in patients, with contradictory findings (71–74), and a clinical trial (NCT02743364)
is ongoing on simvastatin’s effect in alleviating pancreatitis. The
premise of the above studies (as well as a recent study in a mouse
pancreatitis model; ref. 75) is that statins may alter pancreatitis
severity through off-target effects, particularly on inflammation; changes in pancreatic cholesterol were not investigated in
patients with pancreatitis. However, the prevailing opinion is
shifting toward recognizing statins’ potential for pharmacologic prevention of pancreatitis (74). Cholesterol dyshomeostasis is
increasingly recognized as a key player in other multifactorial diseases, such as neurodegenerative (e.g., Alzheimer’s) diseases, in
which it is considered a novel target for treatment (76). Our study
provides evidence for categorizing pancreatitis as a cholesterol
disorder disease and elucidates the mechanisms of the effects of
cholesterol-lowering drugs in pancreatitis.

Methods

Detailed description of the methods is given in the supplemental
material.
Antibodies. Antibodies against the following proteins were purchased from Cell Signaling Technology: ATG12 (catalog 4180), Beclin1
(catalog 3495), ATG7 (catalog 2631), CHOP (catalog 5554), LC3B (catalog 2775), SQSTM1/p62 (catalog 5114), phospho-NF-κB p65/Ser536
(catalog 3033), p44/42 MAPK (ERK1/2; catalog 4696 and 9102), phospho-STAT3/Tyr705 (catalog 9145), and STAT3 (catalog 9139). Antibodies against the following proteins were purchased from Abcam:
CD3 (catalog ab119332), F4/80 (catalog ab6640), LAMP1 (catalog
ab24170), Rab5 (catalog ab18211), Rab9 (catalog ab2810), and SREBP2
(catalog ab30682). Antibodies against the following proteins were
purchased from Santa Cruz Biotechnology: EEA1 (catalog sc-137130),
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Figure 11. Manifestations of disordered
cholesterol homeostasis in human
pancreatitis. (A–F) Immunofluorescence intensity of indicated proteins
in human pancreatic tissue sections
was quantified with Volocity software,
normalized to the number of nuclei
(DAPI) in the field, and is expressed
relative to that in normal pancreas.
Each panel in A–C is from a different
patient (from a total of 21 patients;
see Supplemental Table 1). Scale bars:
10 μm. (D–F) Values are mean ± SEM;
each symbol corresponds to 20 to 30
cells in a different field (n = 10–23 fields
from 10 without pancreatitis and 11
pancreatitis patients). ***P < 0.001 vs.
normal human pancreas (no pancreatitis); 2-tailed Student’s t test.

LAMP1 (catalog sc-17768), LDLR (catalog sc-18823), NF-κB p65 (catalog sc-8008), trypsinogen (catalog sc-137077), and ubiquitin (catalog
sc-8017). Antibodies against the following proteins were purchased
from Sigma-Aldrich: α-amylase (catalog A8273), LAMP2 (catalog
L0668), and Rab7 (catalog R8779). Antibodies against other proteins
were purchased from the following companies: cadherin (Novus, catalog NB200-59), EPG5 (Byorbyt, catalog orb323262), perilipins 2 and
5 (ProGen, catalog GP40 and GP31), perilipin 3 (ProSci, catalog 3881),
myeloperoxidase (Thermo Fisher Scientific, catalog PA5-16672), and
MLN64/STARD3 (Invitrogen, catalog PAS-76266).
Reagents. CellLight Early Endosomes-GFP and Late Endosomes-RFP BacMam 2.0 were from Thermo Fisher Scientific (catalog C10586 and C10589, respectively); Cholesterol and Triglyceride
Assay kits, from Abcam (catalog ab65390 and ab65336); HR series
NEFA-HR2 kits to measure free fatty acids, from Wako Diagnostics
18

(catalog 991-34891); LDL Uptake and ALT Assay kits, from Abcam
(catalog ab133127 and ab105134); and AST Assay kit, from Sigma-
Aldrich (catalog MAK055).
Experimental pancreatitis models in mice were performed as
described previously (8, 31, 46, 48, 77) and detailed in the supplemental material. All the experiments were performed on mice of both sexes if not stated otherwise.
Genetically modified mice. Gnptab–/– (18, 19) and Lamp2–/– mice (8,
78) have been described. Atg5fl/– mice, obtained from Masaki Ohmuraya
(Department of Genetics, Hyogo College of Medicine, Nishinomiya,
Hyogo, Japan) (79), were crossed with Pdx1-Cre driver mice to generate
Atg5fl/–;Pdx1-Cre mice (termed Atg5Δpan) in which the Atg5 gene is specifically ablated in pancreatic epithelial cells. Control mice were littermates with all WT alleles. All these strains of mice are on the C57BL/6
genetic background and have been bred for at least 10 generations.
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Human pancreas specimens. Formalin-fixed, paraffin-embedded samples of human normal pancreas and pancreatitis (see supplemental material) were deidentified and provided by the Pancreas Tissue Bank of the
UCLA Department of Pathology. Tissue sections were evaluated for quality and the presence of an acinar compartment (8, 46).
Human pancreas slices (80) were obtained as detailed in the supplemental material.
Ex vivo pancreatitis models were performed on mouse and human
acinar cells, and human pancreas slices by incubation with supramaximal
CCK (100 nM) or carbachol (1 mM), as described previously (80, 81).
Lipidomics. Unbiased complex lipid analysis of pancreatic samples was performed by the NIH West Coast Metabolomics Center (UC
Davis) using ultra-high-pressure liquid chromatography and tandem
mass spectrometry.
Statistics. Statistical analysis of the results was performed with Prism
8 (GraphPad Software) using a 2-tailed Student’s t test for comparison
between 2 groups and 1-way ANOVA with Tukey’s post hoc test for comparison between multiple groups. Values are expressed as mean ± SEM;
a P value of less than 0.05 was considered significant. Statistical details
for each experiment, including n values, are provided in figure legends.
Study approval. All experimental protocols were approved by the
animal research committee of VA Greater Los Angeles Healthcare
System in accordance with the US NIH Guide for the Care and Use of
Laboratory Animals (National Academies Press, 2011). Deidentified
formalin-fixed, paraffin-embedded samples of human normal pancreas and pancreatitis were provided by the UCLA Pancreas Tissue Bank
according to a protocol approved by UCLA institutional review board.
Human pancreatic slices from portions of live normal human pancreata from preterminal donors that were not used for transplantation
and diverted to research (provided by Trillium Gift of Life Network,
Toronto, Ontario), or from normal portions of pancreatic cancer operations, were obtained according to protocols approved by the University of Toronto institutional review board.
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